Elexacaftor/tezacaftor/ivacaftor in children aged 6–11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24‐week observational study
Salvatore, Donatello, Cimino, Giuseppe, Troiani, Patrizia, Bignamini, Elisabetta, Esposito, Irene, Leonetti, Giuseppina, Zanda, Maurizio, Manunza, Daniela, Pepe, Angela
Published in Pediatric pulmonology (01.09.2022)
Published in Pediatric pulmonology (01.09.2022)
Get full text
Journal Article
Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa
Lenoir, Gerard, Antypkin, Yuriy Genadievich, Miano, Angelo, Moretti, Paolo, Zanda, Maurizio, Varoli, Guido, Monici Preti, Pier Alessandro, Aryayev, Nikolay Leonidovich
Published in Paediatric drugs (2007)
Published in Paediatric drugs (2007)
Get full text
Journal Article
A New Insertion/Deletion of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Accounts for 3.4% of Cystic Fibrosis Mutations in Sardinia: Implications for Population Screening
Faà, Valeria, Bettoli, Pietro Pellegrini, Demurtas, Maria, Zanda, Maurizio, Ferri, Vincenzina, Cao, Antonio, Rosatelli, Maria Cristina
Published in The Journal of molecular diagnostics : JMD (01.09.2006)
Published in The Journal of molecular diagnostics : JMD (01.09.2006)
Get full text
Journal Article
A specific cystic fibrosis mutation (T338I) associated with the phenotype of isolated hypotonic dehydration
Leoni, Giovan Battista, Pitzalis, Sabrina, Podda, Rosanna, Zanda, Maurizio, Silvetti, Mario, Caocci, Luigi, Cao, Antonio, Rosatelli, M.Cristina
Published in The Journal of pediatrics (01.08.1995)
Published in The Journal of pediatrics (01.08.1995)
Get full text
Journal Article